These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28857122)

  • 1. Course of anti-ALK antibody titres during chemotherapy in children with anaplastic large cell lymphoma.
    Mussolin L; Pillon M; Zimmermann M; Carraro E; Basso G; Knoerr F; Woessmann W; Damm-Welk C
    Br J Haematol; 2018 Sep; 182(5):733-735. PubMed ID: 28857122
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk.
    Ait-Tahar K; Damm-Welk C; Burkhardt B; Zimmermann M; Klapper W; Reiter A; Pulford K; Woessmann W
    Blood; 2010 Apr; 115(16):3314-9. PubMed ID: 20185586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
    Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
    Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.
    Cederleuf H; Bjerregård Pedersen M; Jerkeman M; Relander T; d'Amore F; Ellin F
    Br J Haematol; 2017 Sep; 178(5):739-746. PubMed ID: 28485010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series.
    Ruf S; Hebart H; Hjalgrim LL; Kabickova E; Lang P; Steinbach D; Schwabe GC; Woessmann W
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27003. PubMed ID: 29512859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic large cell lymphoma: a single institution experience from India.
    Lakshmaiah KC; Guruprasad B; Shah A; Kavitha S; Abraham LJ; Govindbabu K; Aruna Kumari BS; Appaji L
    J Cancer Res Ther; 2013; 9(4):649-52. PubMed ID: 24518711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic large cell lymphoma presenting as hemophagocytic syndrome in an adolescent.
    Sovinz P; Lackner H; Schwinger W; Benesch M; Urban C; Beham-Schmid C
    Pediatr Blood Cancer; 2007 Dec; 49(7):1057. PubMed ID: 17941063
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravascular large B-cell lymphoma occurring 25 years after treatment of ALK-positive anaplastic large cell lymphoma.
    McKelvie PA; Wools C; Roberts L; Cook M
    Leuk Lymphoma; 2013 Dec; 54(12):2745-7. PubMed ID: 23488602
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.
    Kawamoto K; Suzuki T; Kasami T; Kiryu M; Sone H; Miyoshi H; Ohshima K; Takizawa J
    Hematol Oncol; 2019 Apr; 37(2):212-214. PubMed ID: 30394560
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.
    Sibon D; Fournier M; Brière J; Lamant L; Haioun C; Coiffier B; Bologna S; Morel P; Gabarre J; Hermine O; Sonet A; Gisselbrecht C; Delsol G; Gaulard P; Tilly H
    J Clin Oncol; 2012 Nov; 30(32):3939-46. PubMed ID: 23045585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of anaplastic large-cell lymphoma in children and adolescents: a retrospective multicenter survey study].
    ;
    Zhonghua Er Ke Za Zhi; 2017 Mar; 55(3):194-199. PubMed ID: 28273702
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of ALK-positive anaplastic large cell lymphoma based on CD30 testing.
    Gascoyne RD
    Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 2):3-6. PubMed ID: 24852617
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical features and treatment results in children with anaplastic large cell lymphoma.
    Ataş E; Kutluk MT; Akyüz C; Kale G; Varan A; Yalçın B; Aydın B; Büyükpamukçu M
    Turk J Pediatr; 2015; 57(5):458-66. PubMed ID: 27411412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP3-positive T-cell lymphomas in non-HTLV1 carriers include ALK-negative anaplastic large cell lymphoma: expanding the spectrum of T-cell lymphomas with regulatory phenotype.
    Ferreira CR; Zhao S; Sahoo MK; Pinsky B; Weber J; Lage LAPC; Pereira J; Zerbini MCN; Natkunam Y
    Hum Pathol; 2018 Oct; 80():138-144. PubMed ID: 29898383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous anaplastic large cell lymphoma.
    Daar G; Küpeli S; Yalçin B; Kesik V; Orhan D; Büyükpamukçu M
    Pediatr Hematol Oncol; 2010 Oct; 27(7):558-63. PubMed ID: 20624005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
    Sun XF; Zhen ZJ; Xiang XJ; Ling JY; Peng RJ; Xia Y; Zheng L; Luo WB; Lin H; Guan ZZ
    Ai Zheng; 2009 May; 28(5):506-10. PubMed ID: 19624879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial.
    Sekimizu M; Osumi T; Fukano R; Koga Y; Kada A; Saito AM; Mori T
    Acta Med Okayama; 2018 Aug; 72(4):431-436. PubMed ID: 30140094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma.
    K Singh V; Werner S; Hackstein H; Lennerz V; Reiter A; Wölfel T; Damm-Welk C; Woessmann W
    Clin Exp Immunol; 2016 Oct; 186(1):96-105. PubMed ID: 27414060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term remission of children with relapsed and secondary anaplastic large cell non-Hodgkin lymphoma (ALCL) following treatment with pulsed dexamethasone and low dose etoposide.
    Stockklausner C; Behnisch W; Mechtersheimer G; Möller P; Kulozik AE
    Pediatr Blood Cancer; 2008 Jan; 50(1):126-9. PubMed ID: 16609950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK-negative anaplastic large cell lymphoma with CNS involvement needs more than just brentuximab vedotin.
    Abid MB; Wang S; Loi HY; Poon LM
    Ann Hematol; 2016 Oct; 95(10):1725-6. PubMed ID: 27460479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.